Profiel
Joseph C.
DosSantos worked as Chief Financial Officer at MYOS RENS Technology, Inc. from 2015 to 2016.
He was Chief Financial Officer at CareCloud, Inc. in 2023.
He served as Chief Financial Officer at Luzsana Biotechnology, Inc. from 2021 to 2023.
Mr. DosSantos is expected to be Chief Financial Officer & Senior VP Finance at Celularity, Inc. from 2025 to 2026.
Mr. DosSantos completed an undergraduate degree at Kean University in 1991 and earned an MBA from Seton Hall University.
Eerdere bekende functies van Joseph C. DosSantos
| Bedrijven | Functie | Einde |
|---|---|---|
| CELULARITY INC. | Financieel Directeur/CFO | 27-02-2026 |
| CARECLOUD, INC. | Financieel Directeur/CFO | 10-05-2023 |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Financieel Directeur/CFO | 08-05-2023 |
| MEDAVAIL HOLDINGS, INC. | Algemeen Directeur | 17-12-2015 |
Opleiding van Joseph C. DosSantos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
MYOS RENS Technology, Inc.
MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes therapeutic products, nutritional supplements and other technologies | Health Technology |
Kean University
Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CareCloud, Inc.
CareCloud, Inc. Packaged SoftwareTechnology Services Provides healthcare information technology solutions | Technology Services |
Celularity, Inc.
Celularity, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that discovers cancer sub-types and therapeutic options for cancer patients | Commercial Services |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
















